Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-06-21
2005-06-21
Canella, Karen A. (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021800, C530S350000
Reexamination Certificate
active
06908898
ABSTRACT:
The present invention provides the sequence of a protein capable of acting as an angiostatin receptor as well as the nucleic acid sequence thereof. The invention also relates to the use thereof in screening methods, wherein novel substances are created exhibiting the same advantageous anti-angiogenic properties as angiostatin.
REFERENCES:
patent: 5679350 (1997-10-01), Jankun et al.
patent: 5916572 (1999-06-01), Reed et al.
patent: 0206400 (1986-12-01), None
Troyanovsky et al (Journal of Cell Biology, 2001, vol. 152, pp. 1247-1254).
Amino acid database (U.S. Patent 5,916,572), 1995.
Bork, Peer. Powers and Pitfalls in Sequence Analysis: The 70% Hurdle. Genome Research 10:398-4000, 2000.
Petersen, T. et al. Characterization of the Gene for Human Plasminogen, a Key Proenzyme in the Fibrinolytic System. Journal of Bio. Chem. 205(11):6104-6111, 1990.
Amino acid database, Accession #O13028, 1997.
Amino acid database, Accession #W00024, 1997.
Schartz et al. A superactive insulin: [B10-Aspatic acid] Insulin (human). Proc. Natl. Acad. Sci. 84:6408-6411, 1987.
Lin et al. Structure-Function Relationships in Glucagon: Properties of Highly Purified Des-His(1)-, Monoiodo-, [Des-Asn (28), Thr (29)] (homoserine Lactone (27)-glucagon. Biochemistry 14(8): 1559-1563, 1975.
Biotechnology Industry Organization, Critical Synergy: The Biotechnology Industry and Intellectual Property Protection, 1994.
Claesson-Welsh et al., Proc. Natl. Acad. Sci. USA, Vo., 95, May 1998, pp. 5579-5583.
O'Reilly et al., Nature Medicine, vol., 2, No. 6, Jun. 1996, pp. 689-692.
Wilson et al., Nature, vol. 368, Mar. 3, 1994, pp. 32-38.
Moser, Tammy L. et al.Proc. Natl. Acad. Sci. USA, vol. 96, No. 6, pp. 2811-2816, Mar. 16, 1999.
Claesson-Welsh, Lena,Proc. natl. Acad. Sci. USA, vol. 95, No. 10, pp. 5579-5583, May 12, 1998.
Kost, Christine et al.Eur. J. Biochem, vol. 236, No. 2, pp. 682-688, Mar. 1, 1996.
Database EMSTS Accession No. G16015, Jan. 25, 1996, Murray M. et al. XP002121366.
Holmgren Lars
Troyanovsky Boris
Canella Karen A.
Holmgren Lars
Kenyon & Kenyon
Troyanovsky Boris
LandOfFree
Angiogenesis related molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiogenesis related molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenesis related molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3488255